Biomarkers in aortic dissection

Clinica Chimica Acta

Volumn 412, Issue 9-10, 2011, Pages 688-695

  Wen, Dan ^a   Zhou, Xian Liang ^a   Li, Jian Jun ^a   Hui, Ru Tai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Aortic dissection; Biomarker; Inflammation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIG ENDOTHELIN 1; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALPONIN; D DIMER; ELASTIN; MATRIX METALLOPROTEINASE; MYOSIN HEAVY CHAIN; SOLUBLE ELASTIN FRAGMENT; UNCLASSIFIED DRUG;

AORTA DISSECTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC DISORDER; GENETIC MARKER; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; VASCULITIS;

ANIMALS; AORTIC DISEASES; BIOLOGICAL MARKERS; HUMANS; RISK FACTORS;

EID: 79951725427     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.039     Document Type: Review

References (89)

1. Spittell P.C., Spittell J.A., Joyce J.W., Tajik A.J., Edwards W.D., Schaff H.V., et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc 1993, 68:642-651.
2. Hagan P.G., Nienaber C.A., Isselbacher E.M., Bruckman D., Karavite D.J., Russman P.L., et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000, 283:897-903.
3. Nienaber C.A., Eagle K.A. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation 2003, 108:628-635.
4. Tran T.P., Khoynezhad A. Current management of type B aortic dissection. Vasc Health Risk Manag 2009, 5:53-63.
5. Shimizu K., Mitchell R.N., Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:987-994.
6. Nesi G., Anichini C., Tozzini S., Boddi V., Calamai G., Gori F. Pathology of the thoracic aorta: a morphologic review of 338 surgical specimens over a 7-year period. Cardiovasc Pathol 2009, 18:134-139.
7. Elefteriades J.A. Thoracic aortic aneurysm: reading the enemy's playbook. World J Surg 2008, 32:366-374.
8. Mehta R.H., O'Gara P.T., Bossone E., Nienaber C.A., Myrmel T., Cooper J.V., et al. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol 2002, 40:685-692.
9. Santini F., Luciani G.B., Montalbano G., Messina A., Faggian G., Mazzucco A. Acute type A aortic dissection: an update on a still challenging disease. J Cardiovasc Med Hagerstown 2007, 8:102-107.
10. Khan I.A., Nair C.K. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002, 122:311-328.
11. Golledge J., Eagle K.A. Acute aortic dissection. Lancet 2008, 372:55-66.
12. Luo F., Zhou X.L., Li J.J., Hui R.T. Inflammatory response is associated with aortic dissection. Ageing Res Rev 2009, 8:31-35.
13. Middleton R.K., Bown M.J., Lloyd G.M., Jones J.L., London N.J., Sayers R.D. Characterization of Interleukin-8 and monocyte chemoattractant protein-1 expression within the abdominal aortic aneurysm and their association with mural inflammation. Eur J Vasc Endovasc Surg 2009, 37:46-55.
14. He R., Guo D.C., Estrera A.L., Safi H.J., Huynh T.T., Yin Z., et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg 2006, 131:671-678.
15. Makita S., Ohira A., Tachieda R., Itoh S., Moriai Y., Yoshioka K., et al. Behavior of C-reactive protein levels in medically treated aortic dissection and intramural hematoma. Am J Cardiol 2000, 86:242-244.
16. Li J.J., Wang H.R., Huang C.X., Xue J.L., Li G.S. Enhanced inflammatory response of blood monocytes to C-reactive protein in patients with unstable angina. Clin Chim Acta 2005, 352:127-133.
17. Li J.J., Zhu C.G., Yu B., Liu Y.X., Yu M.Y. The role of inflammation in coronary artery calcification. Aging Res Rev 2007, 6:263-270.
18. Li J.J., Fang C.H. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 2004, 62:499-506.
19. Eggebrecht H., Naber C.K., Bruch C., Kroger K., von Birgelen C., Schmermund A., et al. Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol 2004, 44:804-809.
20. Hata N., Tanaka K., Imaizumi T., Ohara T., Ohba T., Shinada T., et al. Clinical significance of pleural effusion in acute aortic dissection. Chest 2002, 121:825-830.
21. Komukai K., Shibata T., Mochizuki S. C-reactive protein is related to impaired oxygenation in patients with acute aortic dissection. Int Heart J 2005, 46:795-799.
22. Sugano Y., Anzai T., Yoshikawa T., Satoh T., Iwanaga S., Hayashi T., et al. Serum C-reactive protein elevation predicts poor clinical outcome in patients with distal type acute aortic dissection: association with the occurrence of oxygenation impairment. Int J Cardiol 2005, 102:39-45.
23. Schillinger M., Domanovits H., Bayegan K., Holzenbein T., Grabenwoger M., Thoenissen J., et al. C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 2002, 28:740-745.
24. Mir M.A. Aortic dissection-in pursuit of a serum marker. Am J Emerg Med 2008, 26:942-945.
25. Sbarouni E., Georgiadou P., Marathias A., Geroulanos S., Kremastinos D.T. D-dimer and BNP levels in acute aortic dissection. Int J Cardiol 2007, 122:170-172.
26. Vainas T., Lubbers T., Stassen F.R., Herngreen S.B., van Dieijen-Visser M.P., Bruggeman C.A., et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003, 107:1103-1105.
27. Walton L.J., Franklin I.J., Bayston T., Brown L.C., Greenhalgh R.M., Taylor G.W., et al. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 1999, 100:48-54.
28. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573.
29. Sangiorgi G., Trimarchi S., Mauriello A., Righini P., Bossone E., Suzuki T., et al. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection. J Cardiovasc Med Hagerstown 2006, 7:307-315.
30. Curci J.A., Liao S., Huffman M.D., Shapiro S.D., Thompson R.W. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998, 102:1900-1910.
31. Ishii T., Asuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol 2000, 31:640-646.
32. Koullias G.J., Ravichandran P., Korkolis D.P., Rimm D.L., Elefteriades J.A. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004, 78:2106-2110.
33. Loftus I.M., Naylor A.R., Goodall S., Crowther M., Jones L., Bell P.R., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 2000, 31:40-47.
34. McMillan W.D., Tamarina N.A., Cipollone M., Johnson D.A., Parker M.A., Pearce W.H. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 1997, 96:2228-2232.
35. Carrell T.W., Burnand K.G., Wells G.M., Clements J.M., Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002, 105:477-482.
36. Manabe T., Imoto K., Uchida K., Doi C., Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection. Surg Today 2004, 34:220-225.
37. Barutcu I., Karakaya O., Esen A.M., Dogan S., Saglam M., Kargin R., et al. Circulating stromelysin concentration is elevated in hypertensive aortic root dilatation. Heart Vessels 2009, 24:138-141.
38. Karakaya O., Barutcu I., Esen A.M., Dogan S., Saglam M., Karapinar H., et al. Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase-B) concentration and aortic root dilatation. Am J Hypertens 2006, 19:361-365.
39. Solini A., Santini E., Passaro A., Madec S., Ferrannini E. Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals. J Hum Hypertens 2009, 23:801-807.
40. Akiyama M., Ohtani H., Sato E., Nagura H., Tabayashi K. Up-regulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase was coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissection. Virchows Arch 2006, 448:811-821.
41. Chung A.W., Yang H.H., Radomski M.W., van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 2008, 102:e73-e85.
42. Faury G. Function-structure relationship of elastic arteries in evolution: from microfibrils to elastin and elastic fibres. Pathol Biol Paris 2001, 49:310-325.
43. Nakashima Y., Sueishi K. Alteration of elastic architecture in the lathyritic rat aorta implies the pathogenesis of aortic dissecting aneurysm. Am J Pathol 1992, 140:959-969.
44. Shinohara T., Suzuki K., Okada M., Shiigai M., Shimizu M., Maehara T., et al. Soluble elastin fragments in serum are elevated in acute aortic dissection. Arterioscler Thromb Vasc Biol 2003, 23:1839-1844.
45. Akutsu K., Sato N., Yamamoto T., Morita N., Takagi H., Fujita N., et al. A rapid bedside D-dimer assay (cardiac D-dimer) for screening of clinically suspected acute aortic dissection. Circ J 2005, 69:397-403.
46. Hatakeyama K., Asada Y., Marutsuka K., Sato Y., Kamikubo Y., Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997, 133:213-219.
47. Weber T., Hogler S., Auer J., Berent R., Lassnig E., Kvas E., et al. D-dimer in acute aortic dissection. Chest 2003, 123:1375-1378.
48. Weber T., Rammer M., Auer J., Maurer E., Aspock G., Eber B. Plasma concentrations of D-dimer predict mortality in acute type A AD. Heart 2006, 92:836-837.
49. Sodeck G., Domanovits H., Schillinger M., Ehrlich M.P., Endler G., Herkner H., et al. D-dimer in ruling out acute aortic dissection: a systematic review and prospective cohort study. Eur Heart J 2007, 28:3067-3075.
50. Sutherland A., Escano J., Coon T.P. D-dimer as the sole screening test for acute aortic dissection: a review of the literature. Ann Emerg Med 2008, 52:339-343.
51. Marill K.A. Serum D-dimer is a sensitive test for the detection of acute aortic dissection: a pooled meta-analysis. J Emerg Med 2008, 34:367-376.
52. Hata N., Matsumori A., Yokoyama S., Ohba T., Shinada T., Yoshida H., et al. Hepatocyte growth factor and cardiovascular thrombosis in patients admitted to the intensive care unit. Circ J 2004, 68:645-649.
53. Suzuki T., Distante A., Zizza A., Trimarchi S., Villani M., Salerno Uriarte J.A., et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation 2009, 119:2702-2707.
54. Hazui H., Fukumoto H., Negoro N., Hoshiga M., Muraoka H., Nishimoto M., et al. Simple and useful tests for discriminating between acute aortic dissection of the ascending aorta and acute myocardial infarction in the emergency setting. Circ J 2005, 69:677-682.
55. Ohlmann P., Faure A., Morel O., Petit H., Kabbaj H., Meyer N., et al. Diagnostic and prognostic value of circulating D-Dimers in patients with acute aortic dissection. Crit Care Med 2006, 34:1358-1364.
56. Iyano K., Kawada T., Aiba M., Takaba T. Correlation of hemostatic molecular markers and morphology of the residual false lumen in chronic aortic dissection. Ann Thorac Cardiovasc Surg 2004, 10:106-112.
57. Paparella D., Malvindi P.G., Scrascia G., de Ceglia D., Rotunno C., Tunzi F., et al. D-dimers are not always elevated in patients with acute aortic dissection. J Cardiovasc Med Hagerstown 2009, 10:212-214.
58. Evangelista A., Mukherjee D., Mehta R.H., O'Gara P.T., Fattori R., Cooper J.V., et al. Acute intramural hematoma of the aorta: a mystery in evolution. Circulation 2005, 111:1063-1070.
59. Ohlmann P., Faure A., Morel O., Kindo M., Jesel L., Radulescu B., et al. Lower circulating Sta-Lia test D-Di levels in patients with aortic intramural hematoma compared with classical aortic dissection. Crit Care Med 2009, 37:899-901.
60. Hazui H., Nishimoto M., Hoshiga M., Negoro N., Muraoka H., Murai M., et al. Young adult patients with short dissection length and thrombosed false lumen without ulcer-like projections are liable to have false-negative results of D-dimer testing for acute aortic dissection based on a study of 113 cases. Circ J 2006, 70:1598-1601.
61. D'Aloia A., Faggiano P., Brentana L., Dei Cas L. D-dimer serum levels in a case of type B aortic dissection. A rapid test for the early diagnosis of acute aortic disease?. J Cardiovasc Med Hagerstown 2006, 7:216-218.
62. Nomura F., Tamura K., Yoshitatsu M., Katayama A., Katayama K., Ihara K. Changes in coagulation condition, cytokine, adhesion molecule after repair of type A aortic dissection. Eur J Cardiothorac Surg 2004, 26:348-350.
63. Katoh H., Suzuki T., Yokomori K., Suzuki S., Ohtaki E., Watanabe M., et al. A novel immunoassay of smooth muscle myosin heavy chain in serum. J Immunol Meth 1995, 185:57-63.
64. Suzuki T., Katoh H., Tsuchio Y., Hasegawa A., Kurabayashi M., Ohira A., et al. Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection. The smooth muscle myosin heavy chain study. Ann Intern Med 2000, 133:537-541.
65. Suzuki T., Katoh H., Watanabe M., Kurabayashi M., Hiramori K., Hori S., et al. Novel biochemical diagnostic method for aortic dissection. Results of a prospective study using an immunoassay of smooth muscle myosin heavy chain. Circulation 1996, 93:1244-1249.
66. Suzuki T. Cardiovascular diagnostic biomarkers: the past, present and future. Circ J 2009, 73:806-809.
67. Suzuki T., Distante A., Zizza A., Trimarchi S., Villani M., Salerno Uriarte J.A., et al. Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection. Eur Heart J 2008, 29:1439-1445.
68. Wu K.C., Jin J.P. Calponin in non-muscle cells. Cell Biochem Biophys 2008, 52:139-148.
69. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002, 347:161-167.
70. Sodeck G., Domanovits H., Schillinger M., Janata K., Thalmann M., Ehrlich M.P., et al. Pre-operative N-terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J Am Coll Cardiol 2008, 51:1092-1097.
71. Weber M., Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006, 92:843-849.
72. Jankowski M. B-type natriuretic peptide for diagnosis and therapy. Recent Pat Cardiovasc Drug Discov 2008, 3:77-83.
73. Barton M., Yanagisawa M. Endothelin: 20years from discovery to therapy. Can J Physiol Pharmacol 2008, 86:485-498.
74. Wagner A., Domanovits H., Holzer M., Kofler J., Roggla M., Mullner M., et al. Plasma endothelin in patients with acute aortic disease. Resuscitation 2002, 53:71-76.
75. Hemsen A., Ahlborg G., Ottosson-Seeberger A., Lundberg J.M. Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept 1995, 55:287-297.
76. Pacher R., Bergler-Klein J., Globits S., Teufelsbauer H., Schuller M., Krauter A., et al. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol 1993, 71:1293-1299.
77. Adam D.J., Evans S.M., Webb D.J., Bradbury A.W. Plasma endothelin levels and outcome in patients undergoing repair of ruptured infrarenal abdominal aortic aneurysm. J Vasc Surg 2001, 33:1242-1246.
78. Warrens A.N., Cassidy M.J., Takahashi K., Ghatei M.A., Bloom S.R. Endothelin in renal failure. Nephrol Dial Transplant 1990, 5:418-422.
79. Caglayan A.O., Dundar M. Inherited diseases and syndromes leading to aortic aneurysms and dissections. Eur J Cardiothorac Surg 2009, 35:931-940.
80. Morisaki H., Akutsu K., Ogino H., Kondo N., Yamanaka I., Tsutsumi Y., et al. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). Hum Mutat 2009, 30:1406-1411.
81. Zhu L., Vranckx R., Khau Van Kien P., Lalande A., Boisset N., Mathieu F., et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 2006, 38:343-349.
82. Allaire E., Schneider F., Saucy F., Dai J., Cochennec F., Michineau S., et al. New insight in aetiopathogenesis of aortic diseases. Eur J Vasc Endovasc Surg 2009, 37:531-537.
83. McKellar S.H., Tester D.J., Yagubyan M., Majumdar R., Ackerman M.J., Sundt T.M. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007, 134:290-296.
84. Wang Y., Zhang W., Zhang Y., Yang Y., Sun L., Hu S., et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 2006, 113:1615-1621.
85. Chen L., Wang X., Carter S.A., Shen Y.H., Bartsch H.R., Thompson R.W., et al. A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg 2006, 131:1045-1052.
86. Kato K., Oguri M., Kato N., Hibino T., Yajima K., Yoshida T., et al. Assessment of genetic risk factors for thoracic aortic aneurysm in hypertensive patients. Am J Hypertens 2008, 21:1023-1027.
87. Sakakura K., Kubo N., Ako J., Wada H., Fujiwara N., Funayama H., et al. Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension 2010, 2:422-429.
88. Jo Y., Anzai T., Sugano Y., Naito K., Kohno T., Yoshikawa T., et al. Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection. Heart Vessels 2008, 23:334-340.
89. Karapanagiotidis G.T., Antonitsis P., Charokopos N., Foroulis C.N., Anastasiadis K., Rouska E., et al. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia. J Cardiothor Surg 2009, 4:59-64.